Loading...
XNYS
ACH
Market cap34mUSD
Oct 08, Last price  
0.44USD
1D
-6.28%
1Q
-87.04%
Jan 2017
-98.74%
Name

Owens & Minor Inc

Chart & performance

D1W1MN
XNYS:ACH chart
P/E
—
P/S
0.01
EPS
—
Div yield, %
—
Shrs. gr., 5y
4.00%
Rev. gr., 5y
-20.10%
Revenues
2.76b
-74.19%
5,533,736,0006,800,466,0007,243,237,0008,037,624,0008,123,608,0008,627,912,0008,908,145,0009,071,532,0009,440,182,0009,772,946,0009,723,431,0009,318,275,0009,838,708,0009,210,939,0008,480,177,0009,785,315,0009,955,475,00010,333,967,00010,700,883,0002,762,032,000
Net income
-1.10b
L+203.47%
48,752,00072,710,00093,327,000104,658,000110,579,000115,198,000109,003,000110,882,00066,503,000103,409,000108,787,00072,793,000-437,012,000-62,371,00029,871,000221,589,00022,389,000-41,301,000-362,686,000-1,100,642,000
CFO
0
-100.00%
-73,580,000219,840,00075,813,000175,577,000242,923,00068,141,000218,506,000140,554,000-3,761,000269,597,000186,934,00056,774,000115,589,000166,085,000339,223,000124,177,000325,006,000740,710,000161,495,0000
Dividend
Dec 14, 20210.002 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Owens & Minor, Inc., along with its affiliated entities, operates as a global provider of healthcare solutions, serving markets both within the United States and internationally. Its business is structured into two primary divisions: Global Solutions and Global Products. The Global Solutions segment delivers a comprehensive array of products and services tailored for healthcare providers and manufacturers. This includes a range of medical and surgical provisions, encompassing both well-known brands and O&M's own proprietary items. Additionally, this division offers crucial services to healthcare providers, such as supplier management, data analytics, inventory control, and clinical supply oversight. It also develops various programs to provide logistical support and marketing strategies for its network of suppliers. Conversely, the Global Products segment focuses on manufacturing and procuring medical and surgical items designed to prevent infections acquired in healthcare settings, serving both acute care facilities and alternative site channels. Its diverse product portfolio features sterilization wraps, surgical drapes and gowns, facial protection gear, various protective apparel, medical examination gloves, customized and minor procedure kits, among other essential medical supplies. O&M supplies its extensive range of offerings directly to a broad client base, which includes large multi-facility healthcare provider networks, independent hospitals, surgical centers, physician's practices, and hospital systems. Distribution also occurs indirectly through collaborations with third-party partners. Founded in 1882, the company maintains its principal corporate office in Richmond, Virginia.

Key people

Edward Pesicka
President, Chief Executive Officer, Director · since 2019
Perry Bernocchi
Chief Operating Officer, Executive Vice President · since 2025
Jonathan Leon
Chief Financial Officer, Executive Vice President, Principal Accounting Officer · since 2025
Snehashish Sarkar
Executive Vice President, Chief Information Officer · since 2024
Heath Galloway
Executive Vice President, General Counsel, Corporate Secretary · since 2023
Independent Chairman of the Board · since 2020
Gwendolyn Bingham
Independent Director · since 2020
Kenneth Gardner-Smith
Independent Director · since 2022
Robert Henkel
Independent Director · since 2019
Rita Johnson-Mills
Independent Director · since 2022
Stephen Klemash
Independent Director · since 2021
Independent Director · since 2022
Carissa Rollins
Independent Director · since 2022
IPO date
Mar 17, 1980
Employees
22,500
Domiciled in
US
Incorporated in
US
Legal address
C/O C T CORPORATION SYSTEM
4701 Cox Rd Ste 285
Glen Allen, VA 23060
US
Headquarters
9120 Lockwood Boulevard
Mechanicsville, VA 23116
US
Previous name
OMI HOLDING, INC.
Previous name
O&M HOLDING, INC.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT